Organon & Co | OGN - 売上総利益





売上総利益 変化する 日付
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Celltrion KRW 39.29B 7.7B 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
Glaxosmithkline GBP 5.75B 2.99B 2026-03
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Merck USD 12.09B 1.24B 2026-03
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Novartis USD 10.07B 758M 2026-03
Organigram Holdings CAD 16.41M 6.91M 2026-03
Organon & Co USD 847M 64M 2026-06
Pharma Mar EUR 44.87M 5.63M 2026-06
Qiagen NV USD 340.39M 30.78M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tilray USD 57.47M 10.16M 2025-06
Zealand Pharma A/S 34M 34.92M 2026-03